Couverture de The Hatch Podcast

The Hatch Podcast

The Hatch Podcast

De : The Hatch Podcast Network
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce contenu audio

At the intersection of innovation, creativity, and community — The Hatch Podcast shares stories from founders, scientists, and artists shaping the future of Alabama’s Gulf Coast. Produced at Hatch Fairhope, it’s where bold ideas take flight.


The Founders Series dives into the journeys of startup founders building the future of business, technology, and innovation across the Gulf South.


The Music Accelerator combines professional music industry guidance with spiritual mentorship, creating a unique environment where artists can grow both creatively and personally. Hosted by music industry veteran Chris Estes, this series features conversations with artists and insiders who’ve spent years shaping the sounds and stories of modern music.


The Bioscience Innovation Series explores breakthroughs in healthcare, agriculture, and environmental science — with founders and researchers driving life-changing discoveries in labs across the region.


Around the Table features conversations with Alabama’s most forward-thinking companies and creators, from startups re-imagining industry to leaders building stronger communities.


And throughout the year, The Hatch Podcast Network introduces new limited series spotlighting the people and ideas transforming the Gulf Coast economy — one story at a time.


Find out more at hatchfairhope.com

Contact: team@hatchfairhope.com



© 2026 The Hatch Podcast
Art Economie
Épisodes
  • Would You Let a Robot Draw Your Blood? Ravi Kaushik on ROPHAI
    Nov 13 2026

    Would you let a robot draw your blood?

    For anyone who gets nervous around needles, the idea might raise a few questions. But Ravi Kaushik believes robotics and artificial intelligence could help address some of the challenges behind a familiar medical procedure.

    In this episode of The Hatch Podcast, Tim Scott talks with Ravi, founder and CEO of ROPHAI, a company developing a human-assisted robotic system for drawing blood.

    Calling in from Boston, Ravi explains how the device uses imaging to locate a vein and guide a needle, while a technician remains involved in the process. He also describes the machine learning behind the technology, how people have responded during testing, and the development work ahead as the company works toward FDA clearance.

    Ravi shares what led him from a career in medical technology to starting ROPHAI, the partnerships he’s looking to build, and how the Hatch Biotech Accelerator, powered by Bessel, connects his work to Fairhope and the Gulf Coast.

    In this episode:

    • The staffing and skill challenges behind everyday blood draws
    • What happens when a technician brings the robot beside a patient
    • How imaging and machine learning guide the process
    • How donors and patients have responded to the technology
    • ROPHAI’s development progress and path toward FDA clearance
    • Ravi’s experience with the Hatch Biotech Accelerator and the support he’s seeking

    Featured in This Episode

    Ravi Kaushik
    Founder & CEO
    ROPHAI

    Learn More:

    ROPHAI

    Ravi Kaushik on LinkedIn

    Email Ravi: ravikaushik@rophai.com

    ROPHAI is seeking clinical, engineering, and manufacturing partners, along with funding, mentorship, and advice.

    About Hatch:

    Hatch Fairhope
    https://hatchfairhope.com

    Produced by Tim Scott
    in/timscottproductions

    Afficher plus Afficher moins
    16 min
  • Giving Stroke Treatment a Sense of Touch: Evan Austill on Perceptive Robotics
    Nov 4 2026

    Every 40 seconds, someone in the United States has a stroke. When a blood clot blocks an artery in the brain, every minute matters. But physicians performing clot-removal procedures face a significant challenge: they can't always see exactly where the clot begins.

    Perceptive Robotics is developing technology that could help change that.

    In this episode of The Hatch Podcast, Tim Scott talks with Evan Austill, co-founder and Chief Development Officer of Perceptive Robotics, a Vanderbilt University spinout developing a new approach to stroke treatment.

    The company's first product, LumenSense, is designed to give physicians a sense of touch during catheter-based procedures. The small device attaches to existing aspiration catheters, helping physicians determine when the catheter tip has reached a blood clot without requiring changes to the equipment or procedure they're already using.

    Evan shares how eight years of Vanderbilt research led to the company, the progress they've made through preclinical testing, and what lies ahead as they work toward FDA clearance. He also discusses his experience building medical technology companies, the challenges of bringing new devices to market, and how Hatch's Powered by Bessel accelerator is helping connect Perceptive Robotics with the broader medical technology community.

    In this episode:

    • Why locating blood clots during stroke procedures can be difficult
    • How LumenSense adds sensing capabilities to existing catheters
    • The Vanderbilt research behind Perceptive Robotics
    • The path from medical innovation to FDA clearance
    • Lessons from Evan's experience building and financing medical technology companies
    • The company's next milestones and its connection to Hatch

    Featured in This Episode

    Evan Austill Jr.
    Co-Founder & Chief Development Officer
    Perceptive Robotics

    Learn More:

    Perceptive Robotics
    https://perceptiverobotics.ai

    Evan Austill on LinkedIn
    https://www.linkedin.com/in/evanaustill/


    About Hatch:

    Hatch Fairhope
    https://hatchfairhope.com

    Produced by Tim Scott
    in/timscottproductions

    Afficher plus Afficher moins
    14 min
  • Breaking the Blood-Brain Barrier: Afreen Allam on the Future of Brain Medicine
    Oct 27 2026

    What if the biggest obstacle to treating diseases like Alzheimer's, Parkinson's, and brain cancer isn't the medicine itself, but getting that medicine where it needs to go?

    In Episode 58 of The Hatch Podcast, producer Tim Scott sits down with Afreen Allam, founder and CEO of SiNON Nano Sciences, a biotech company developing an innovative approach to delivering medications across the blood-brain barrier.

    Afreen explains how her team is using carbon-based nanoparticles as a kind of Trojan horse to carry medications into the brain, potentially opening the door to safer, less invasive treatments for neurological diseases.

    She also shares the personal experiences that inspired her journey into biotech, including seven years volunteering with cancer patients at Duke Cancer Center, the challenges of developing new medical technology, and what brought SiNON to Hatch's biotech accelerator in Fairhope, Alabama.

    WHAT YOU'LL LEARN

    • Why the blood-brain barrier prevents most medications from reaching the brain
    • How SiNON's Trojan horse approach could change drug delivery
    • The potential advantages of less invasive treatments for neurological diseases
    • How volunteering with cancer patients shaped Afreen's career
    • The challenges of developing and funding new biotech technology
    • Why Afreen joined Hatch and the partnerships she's looking to build

    FEATURED IN THIS EPISODE

    Afreen Allam
    Founder & CEO, SiNON Nano Sciences
    Website: https://sinontx.com
    LinkedIn: https://www.linkedin.com/in/afreenallam/

    LEARN MORE

    Hatch Fairhope
    https://hatchfairhope.com

    Hatch Events & Meetups
    https://hatchfairhope.com/events

    Produced by Tim Scott

    https://timscott.me

    Afficher plus Afficher moins
    15 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment